Market Overview
The Zygomatic and Pterygoid Implants Market is expected to register a CAGR of 5.9% during the forecast period. Zygomatic and Pterygoid implants are used when the patient has insufficient quality or quantity of bone to anchor implants of regular dimensions. For patients suffering from severe maxillary resorption, extensive grafting procedures takes long treatment time an alternate method is to anchor an implant into the Zygomatic bone and this implant provides better patient satisfaction and allows patients to return to a normal quality of life and Zygomatic implant has become implant of choice for cases of the severely resorbed maxilla. Pterygoid implant insertion is an alternative method to grafting procedures or to avoid sinus-lifting to treat the posterior maxilla. Pterygoid implants have high success rates due to minimal complications and good patient acceptance. Increasing geriatric population increases the incidence of dental ailments and injuries and proven advantageous procedures with implants as against conventional substitutes are the key driving factors in the zygomatic and pterygoid implants market.
Scope of the Report
Zygomatic and Pterygoid Implants are used when the patient has insufficient quality or quantity of bone to anchor implants of regular dimensions. Zygomatic and Pterygoid Implants Market are segmented by Application and Geography.
Key Market Trends
Severe Atrophy of Maxillary Bone Segment is Expected to Hold a Major Market Share by Application in the Zygomatic and Pterygoid Implants Market.
- Severe atrophy of maxillary bone is due to bone pneumatization and resorption of the maxillary sinus which is a common condition in the older population. Zygomatic implant placement is a highly predictable procedure with a high success rate in the restoration of atrophic jaws, without the need for complex bone augmentation procedures.
- According to World Health Organization (WHO), by the year 2050, one in six people in the world will be over 65 years of age (16%), up from one in 11 in the year 2019 (9%).
- Severe atrophy of the maxillary bone segment holds a major market share and is expected to grow significantly over the forecast period.
- Rising geriatric population, increasing incidence of dental ailments and injuries are the key driving factors in the severe atrophy of the maxillary bone segment.
Europe is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period
Europe expected to hold a major market share in the global zygomatic and pterygoid implants market due to the increasing geriatric population leading to a rise in incidence rates of dental ailments and injuries. By the year 2050, one in four people living in Europe and Northern America region could be aged 65 or over and the number of persons aged over 80 years of age is projected to be triple, from 143 million in the year 2019 to 426 million by the year 2050. Moreover, the high adoption rates of new technologies and favorable reimbursements for dental implantation is also fueling the growth of the overall regional market to a large extent.
Competitive Landscape
The Zygomatic and Pterygoid Implants Market is moderately consolidated competitive and consists of few players. In terms of market share, few of the major players are currently dominating the market. Some of the companies which are currently dominating the market are Straumann Holding AG, Noris Medical, S.I.N. Implant System, Southern Implants, IDC Implant & Dental Company, Danaher Corporation (Envista), Titaniumfix, Implance, Bioline Dental Implants, Osseosource.
Reasons to Purchase this report:
- The market estimate (ME) sheet in Excel format
- Report customization as per the client’s requirements
- 3 months of analyst support